Sobr Safe Inc Stock Price, News & Analysis

SOBRsafe (NASDAQ: SOBR) has appointed Kris Pederson to its Board of Directors, effective May 1, 2025. Pederson, a former EY partner who led the firm's Center for Board Matters and Americas Strategy Consulting practice, brings 30 years of experience in management consulting, auditing, and corporate governance. She previously held leadership positions at IBM and PriceWaterhouseCoopers.

Additionally, the company appointed Dr. Benjamin Sanchez as Scientific Advisor in February 2025. Dr. Sanchez, an Associate Professor at the University of Illinois Chicago, will focus on accelerating non-dilutive federal funding, licensing, and strengthening relationships with clinical research organizations for alcohol detection testing.

SOBRsafe (NASDAQ:SOBR), a leader in next-generation alcohol monitoring technology, provided a corporate update highlighting its 2024 achievements and 2025 initiatives. The company reported 35% year-over-year revenue growth to $212.7K for 2024, with a 20% decrease in operating expenses and 16% improvement in net loss.

Key developments include: expansion to 43 U.S. states and international markets including Canada, Australia, and New Zealand; securing orders for 350 SOBRsure bands for 2025 delivery; and completing third-party product validations. The company maintains a strong financial position with $8.4 million in cash and no long-term debt as of December 31, 2024.

Recent corporate actions include a 1-for-10 reverse stock split on April 2, 2025, reducing outstanding shares from 15.2M to 1.5M, and successful warrant exercises generating $5M in net proceeds across Q4 2024 and Q1 2025.

SOBRsafe (NASDAQ: SOBR) has released a comprehensive survey revealing significant insights about alcohol consumption among middle-aged American women. The Censuswide study of 1,001 women aged 40-65 shows that 30% are moving toward sober living while 45% express concerns about dependency.

The survey highlights concerning trends among women in their 40s:

• 28% drink more than in their 20s
• Over 1/3 use alcohol for anxiety management
• 28% increased drinking after breakups
• 40% of single women use alcohol for first-date anxiety

The study also reveals health impacts: 32% report gut health issues, 27% experience disrupted sleep, and 23% face memory issues. Major barriers to seeking help include embarrassment (18%), reluctance to quit (32%), and financial limitations (16%). The research coincides with the U.S. Surgeon General's warning about alcohol-cancer links and Alcohol Awareness Month.

SOBRsafe (NASDAQ:SOBR) has announced a 1-for-10 reverse stock split of its common stock, effective April 4, 2025. The split will reduce outstanding shares from approximately 15,161,445 to 1,516,145 shares. Trading will continue under the symbol 'SOBR' with a new CUSIP number 833592 405.

The reverse split, approved by shareholders on December 9, 2024, will apply equally to all outstanding shares, with stockholders maintaining their same percentage ownership except for minor adjustments from fractional shares. Fractional shares will be rounded up to the nearest whole number. All securities including warrants and equity compensation awards will be proportionately adjusted.

Equiniti Trust Company is serving as the exchange agent. Stockholders with electronic book-entry shares require no action, while those holding certificates will receive instructions for exchanging their shares.

SOBRsafe (NASDAQ:SOBR) and Orbiit have announced a strategic AI partnership to enhance alcohol recovery solutions. The collaboration combines SOBRsafe's transdermal alcohol detection wristband with Orbiit's AI-powered engagement platform to provide comprehensive support for individuals managing sobriety.

The partnership addresses a significant market need, as over 28 million Americans suffered from Alcohol Use Disorder (AUD) in 2023, with only 15.6% receiving treatment. The solution integrates three key components: the SOBRsure Band for continuous alcohol detection, AI-Powered Orbie for 24/7 support, and SMS accountability messaging.

The Orbiit Recovery Program is priced at $3,995 for a six-month program, including the SOBRsure band and full access to Orbiit's AI platform. The program combines wearable technology with behavioral science principles to enhance accountability, motivation, and long-term recovery success.

SOBR Safe Inc (NASDAQ:SOBR) has launched SOBRsure, a new wristband device that detects alcohol through skin contact using transdermal technology. The device retails for $249 with subscription options of $39.99/month (BASIC) or $59.99/month (PLUS). Key features include real-time alcohol detection, GPS tracking, instant alerts, and historical reporting capabilities.

The water-resistant wristband resembles a fitness tracker and will begin shipping by end of November 2024. It's designed to support sobriety monitoring for individuals, families, and businesses, particularly in high-risk industries like transportation and construction. The system includes an enhanced app experience and provides continuous feedback for maintaining accountability.

SOBRsafe (NASDAQ:SOBR) announced it has regained compliance with Nasdaq's listing requirements, including minimum bid price, public float, and stockholders' equity rules. The company will continue trading on The Nasdaq Capital Market under 'SOBR'. Following the October 30, 2024 compliance letter, SOBRsafe enters a mandatory one-year monitoring period. If found non-compliant with the Equity Rule during this period, the company will face immediate delisting procedures without a cure period, though it may request a new hearing.

SOBRsafe, Inc. (NASDAQ:SOBR) has launched a fully-integrated enterprise software solution for alcohol detection and monitoring in behavioral health settings. The platform combines SOBRcheck™ for point-of-care screening and SOBRsure™ for continuous monitoring, offering real-time visibility across multiple users and locations in one dashboard.

Key features include:

• Touch-based transdermal alcohol detection, eliminating need for breath, blood, or urine samples
• Instant reporting accessible via computer or mobile device
• Integration with electronic medical records (EMR)
• Robust lookback capabilities for demonstrating compliance

This innovative solution aims to transform how behavioral health providers monitor alcohol use, enhance responsiveness, reduce recidivism, and improve patient outcomes in addiction and alcohol use disorder (AUD) treatment.

SOBR Safe, Inc. (NASDAQ:SOBR) has successfully completed a private placement of $8.2 million, with Aegis Capital Corp. acting as the exclusive placement agent. This financial transaction, announced on October 9, 2024, represents a significant capital raise for the company. The private placement structure suggests that the shares were offered to a select group of investors rather than the general public.

While the press release does not provide details on the specific use of funds or the terms of the placement, such capital raises are typically used to support company growth, fund research and development, or strengthen the balance sheet. For SOBR Safe, this injection of capital could potentially accelerate its business initiatives and enhance its market position.